Connected mechanistic process modeling to predict a commercial biopharmaceutical downstream process
Federico Rischawy(Boehringer Ingelheim (Germany)), Jürgen Hubbuch(Karlsruhe Institute of Technology), Simon Kluters(Boehringer Ingelheim (Germany)), David Saleh(Boehringer Ingelheim (Germany)), Gang Wang(Beijing University of Technology), Till Briskot(Boehringer Ingelheim (Germany)), Nathalie Hopf(Boehringer Ingelheim (Germany)), Joey Studts(Boehringer Ingelheim (Germany))
Cited by 22
Related Papers
Good modeling practice for industrial chromatography: Mechanistic modeling of ion exchange chromatography of a bispecific antibody
|Computers & Chemical Engineering|2019|71
Straightforward method for calibration of mechanistic cation exchange chromatography models for industrial applications
|Biotechnology Progress|2020|63
Cross‐scale quality assessment of a mechanistic cation exchange chromatography model
|Biotechnology Progress|2020|28
<i>In silico</i> process characterization for biopharmaceutical development following the quality by design concept
|Biotechnology Progress|2021|28
A multiscale modeling method for therapeutic antibodies in ion exchange chromatography
|Biotechnology and Bioengineering|2022|24